CRB
Chad R. Baker Portfolio holdings
AUM
$538M
This Quarter Return
+12.2%
1 Year Return
+20.8%
3 Year Return
+87.18%
5 Year Return
+140.51%
10 Year Return
–
AUM
$483M
AUM Growth
+$483M
(+8.4%)
Cap. Flow
-$7.57M
Cap. Flow
% of AUM
-1.57%
Top 10 Holdings %
Top 10 Hldgs %
44.28%
Holding
54
New
2
Increased
–
Reduced
4
Closed
4
Top Buys
| 1 |
Beam Therapeutics
BEAM
|
$2.2M |
| 2 |
Pacific Biosciences
PACB
|
$1.7M |
Top Sells
| 1 |
Teladoc Health
TDOC
|
$3.23M |
| 2 |
Fiserv
FI
|
$2.6M |
| 3 |
Becton Dickinson
BDX
|
$2.46M |
| 4 |
Apple
AAPL
|
$1.53M |
| 5 |
RTX Corp
RTX
|
$718K |
Sector Composition
| 1 | Technology | 22.09% |
| 2 | Healthcare | 20.2% |
| 3 | Industrials | 16.73% |
| 4 | Consumer Discretionary | 13.43% |
| 5 | Communication Services | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Illumina
ILMN
$15.2B
| $8.3M | 1.72% |
21,825
| – | – |
|
27
T-Mobile US
TMUS
$289B
| $8.24M | 1.71% |
71,030
| – | – |
|
28
Sysco
SYY
$38.5B
| $7.7M | 1.59% |
98,015
| – | – |
|
29
Lowe's Companies
LOW
$145B
| $7.26M | 1.5% |
28,100
| – | – |
|
30
Home Depot
HD
$405B
| $7.06M | 1.46% |
17,000
| – | – |
|
31
Alphabet (Google) Class C
GOOG
$2.53T
| $6.53M | 1.35% |
2,256
| – | – |
|
32
Zoetis
ZTS
$67.2B
| $6.06M | 1.25% |
24,818
| – | – |
|
33
Stryker
SYK
$148B
| $5.12M | 1.06% |
19,145
| – | – |
|
34
Adobe
ADBE
$146B
| $5.1M | 1.06% |
9,000
| – | – |
|
35
Walmart
WMT
$777B
| $4.78M | 0.99% |
33,000
| – | – |
|
36
Colgate-Palmolive
CL
$68B
| $4.37M | 0.9% |
51,200
| – | – |
|
37
Medtronic
MDT
$120B
| $3.89M | 0.8% |
37,550
| – | – |
|
38
CSX Corp
CSX
$59.8B
| $3.84M | 0.79% |
102,000
| – | – |
|
|
39
RTX Corp
RTX
$212B
| $3.3M | 0.68% |
38,348
-8,348
| -18% | -$718K |
|
40
3M
MMM
$82.2B
| $2.84M | 0.59% |
16,000
| – | – |
|
|
41
Beam Therapeutics
BEAM
$1.65B
| $2.2M | 0.45% |
+27,550
| New | +$2.2M |
|
|
WIRE
42
DELISTED
Encore Wire Corp
WIRE
| $1.86M | 0.39% |
13,000
| – | – |
|
|
43
Pacific Biosciences
PACB
$378M
| $1.7M | 0.35% |
+82,875
| New | +$1.7M |
|
44
Merck
MRK
$212B
| $1.66M | 0.34% |
21,700
| – | – |
|
45
Pfizer
PFE
$141B
| $1.45M | 0.3% |
24,500
| – | – |
|
46
Cigna
CI
$80.4B
| $1.34M | 0.28% |
5,841
| – | – |
|
47
Canadian National Railway
CNI
$60.1B
| $1.24M | 0.26% |
10,050
| – | – |
|
48
Fortive
FTV
$15.8B
| $1.14M | 0.24% |
15,000
| – | – |
|
49
Exxon Mobil
XOM
$489B
| $1M | 0.21% |
16,400
| – | – |
|
50
J.M. Smucker
SJM
$11.6B
| $231K | 0.05% |
1,700
| – | – |
|